The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Odyssey of a cancer nanoparticle: From injection site to site of action
Open accessAbstract
No chemotherapeutic drug can be effective until it is delivered to its target site. Nano-sized drug carriers are designed to transport therapeutic or diagnostic materials from the point of administration to the drug’s site of action. This task requires the nanoparticle carrying the drug to complete a journey from the injection site to the site of action. The journey begins with the injection of the drug carrier into the bloodstream and continues through stages of circulation, extravasation, accumulation, distribution, endocytosis, endosomal escape, intracellular localization and—finally—action. Effective nanoparticle design should consider all of these stages to maximize drug delivery to the entire tumor and effectiveness of the treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Weinberg, R. A., & Weinberg, R. A. (2006) · W.W. Norton eBooks · doi:10.1201/9780203852569 · Cited by 1,751
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337
Mukherjee, S., Ghosh, R. N., & Maxfield, F. R. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.759 · Cited by 1,294
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J. S., Chin, S.-F., Sherry, A. D., Boothman, D. A., & Gao, J. (2006) · Nano Letters · doi:10.1021/nl061412u · Cited by 1,238
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Jaeger, H. M., & Nagel, S. R. (1992) · Science · doi:10.1126/science.255.5051.1523 · Cited by 1,138
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Lu, J., Liong, M., Li, Z., Zink, J. I., & Tamanoi, F. (2010) · Small · doi:10.1002/smll.201000538 · Cited by 1,074
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology
Oberdörster, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02187.x · Cited by 943
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
(1990) · PubMed · Cited by 757
Targeting the tumour vasculature: insights from physiological angiogenesis
Chung, A. S., Lee, J., & Ferrara, N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2868 · Cited by 752
At the acidic edge: emerging functions for lysosomal membrane proteins
Eskelinen, E.-L., Tanaka, Y., & Saftig, P. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00005-9 · Cited by 660
Pluen, A., Boucher, Y., Ramanujan, S., McKee, T. D., Gohongi, T., di Tomaso, E., Brown, E. B., Izumi, Y., Campbell, R. B., Berk, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081626898 · Cited by 603
ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
Eckford, P. D. W., & Sharom, F. J. (2009) · Chemical Reviews · doi:10.1021/cr9000226 · Cited by 597
Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. M., Peters, A. M., Vile, R. G., & Stewart, J. S. W. (2001) · PubMed · Cited by 575
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Diffusion and Convection in Collagen Gels: Implications for Transport in the Tumor Interstitium
Ramanujan, S., Pluen, A., McKee, T. D., Brown, E. B., Boucher, Y., & Jain, R. K. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)73933-7 · Cited by 552
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 552
Kumar, R., Roy, I., Ohulchanskky, T. Y., Vathy, L. A., Bergey, E. J., Sajjad, M., & Prasad, P. N. (2010) · ACS Nano · doi:10.1021/nn901146y · Cited by 548
Ozao-Choy, J., Ma, G., Kao, J., Wang, G. X., Meseck, M., Sung, M., Schwartz, M., Divino, C. M., Pan, P.-Y., & Chen, S.-H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4709 · Cited by 538
Boucher, Y., & Jain, R. K. (1992) · PubMed · Cited by 510
Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
Shapira, A., Livney, Y. D., Broxterman, H. J., & Assaraf, Y. G. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.003 · Cited by 504
Establishment of human tumor xenografts in immunodeficient mice
Morton, C. L., & Houghton, P. J. (2007) · Nature Protocols · doi:10.1038/nprot.2007.25 · Cited by 489
Stylianopoulos, T., Poh, M.-Z., Insin, N., Bawendi, M. G., Fukumura, D., Munn, L. L., & Jain, R. K. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.06.016 · Cited by 443
Biomédical applications of nanotechnology — implications for drug targeting and gene therapy
Davis, S. S. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01036-6 · Cited by 416
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 413
Kwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90118-x · Cited by 409
Characterization of Nanoparticles for Therapeutics
Hall, J. B., Dobrovolskaia, M. A., Patri, A. K., & McNeil, S. E. (2007) · Nanomedicine · doi:10.2217/17435889.2.6.789 · Cited by 409
Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406
Lindman, S., Lynch, I., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Nano Letters · doi:10.1021/nl062743+ · Cited by 377
Nanomedicines and nanotoxicology: some physiological principles
Garnett, M. C., & Kallinteri, P. (2006) · Occupational Medicine · doi:10.1093/occmed/kql052 · Cited by 352
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Mikhail, A. S., & Allen, C. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.010 · Cited by 328
Protracted elimination of gold nanoparticles from mouse liver
Sadauskas, E., Danscher, G., Stoltenberg, M., Vogel, U., Larsen, A., & Wallin, H. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.11.002 · Cited by 328
Solid stress generated by spheroid growth estimated using a linear poroelasticity model☆
Roose, T., Netti, P. A., Munn, L. L., Boucher, Y., & Jain, R. K. (2003) · Microvascular Research · doi:10.1016/s0026-2862(03)00057-8 · Cited by 301
Can cancer be reversed by engineering the tumor microenvironment?
Ingber, D. E. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.016 · Cited by 298
(2000) · PubMed · Cited by 295
Conditional mouse models of sporadic cancer
Jonkers, J., & Berns, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc777 · Cited by 294
Min, K. H., Kim, J.-H., Bae, S. M., Shin, H., Kim, M. S., Park, S., Lee, H., Park, R.-W., Kim, I.-S., Kim, K., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.024 · Cited by 287
Ong, S., Liu, H., & Pidgeon, C. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(95)00837-3 · Cited by 266
Docetaxel-related side effects and their management
Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M. S., & von Minckwitz, G. (2009) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2008.10.003 · Cited by 261
Uptake of dextran‐coated monocrystalline iron oxides in tumor cells and macrophages
Moore, A., Weissleder, R., & Bogdanov, A. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070629 · Cited by 260
Biodegradable Nanoparticles Composed Entirely of Safe Materials that Rapidly Penetrate Human Mucus
Yang, M., Lai, S. K., Wang, Y., Zhong, W., Happe, C., Zhang, M., Fu, J., & Hanes, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006849 · Cited by 260
Direct Measurement of a Tethered Ligand-Receptor Interaction Potential
Wong, J. Y., Kuhl, T. L., Israelachvili, J. N., Mullah, N., & Zalipsky, S. (1997) · Science · doi:10.1126/science.275.5301.820 · Cited by 255
Eikenes, L., Bruland, Ø. S., Brekken, C., & Davies, C. D. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1472 · Cited by 251
Silica nanoparticles as hepatotoxicants
Nishimori, H., Kondoh, M., Isoda, K., Tsunoda, S.-I., Tsutsumi, Y., & Yagi, K. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.02.005 · Cited by 243
Evaluation of iron oxide nanoparticle biocompatibility
Gavard, J., Hanini, Schmitt, Kacem, Chau, Ammar, & Gavard, J. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17574 · Cited by 241
Liposomal, Nanoparticle, and Conjugated Formulations of Anticancer Agents
Zamboni, W. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1895 · Cited by 234
Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Parving, H.-H., Hansen, J. M., Nielsen, S. L., Rossing, N., Munck, O., & Lassen, N. A. (1979) · New England Journal of Medicine · doi:10.1056/nejm197908303010902 · Cited by 226
Wu, A. M., Yazaki, P. J., Tsai, S.-W., Nguyen, K., Anderson, A.-L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150228297 · Cited by 214
Zhang, C., Qu, G., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.029 · Cited by 205
Characterization of the mononuclear phagocyte system in zebrafish
Wittamer, V., Bertrand, J. Y., Gutschow, P. W., & Traver, D. (2011) · Blood · doi:10.1182/blood-2010-11-321448 · Cited by 205
Interstitial fluid pressure in intracranial tumours in patients and in rodents
Boucher, Y., Salehi, H., Witwer, B., Harsh, G., & Jain, R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.148 · Cited by 191
Vail, D. M., Amantea, M. A., Colbern, G. T., Martin, F. J., Hilger, R. A., & Working, P. K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.002 · Cited by 187
Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier
Chithrani, D. B., Dunne, M., Stewart, J., Allen, C., & Jaffray, D. A. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.04.009 · Cited by 187
Lee, C. M., & Tannock, I. F. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-255 · Cited by 161
Kunath, K., von Harpe, A., Petersen, H., Fischer, D., Voigt, K., Kissel, T., & Bickel, U. (2002) · Pharmaceutical Research · doi:10.1023/a:1016152831963 · Cited by 158
Xiao, Z., Levy‐Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J. W. M., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
Richardson, P. G. G., Schlossman, R. L., Jagannath, S., Alsina, M., Desikan, R. K., Blood, E., Weller, E. A., Mitsiades, C. S., Hideshima, T., Davies, F. E., et al. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.7.875 · Cited by 130
Gao, J., Chen, K., Luong, R. H., Bouley, D. M., Mao, H., Qiao, T., Gambhir, S. S., & Cheng, Z. (2011) · Nano Letters · doi:10.1021/nl203526f · Cited by 127
Flessner, M. F., Choi, J., Credit, K., Deverkadra, R., & Henderson, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2332 · Cited by 114
Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport
Sharom, F. J., Yu, X., DiDiodato, G., & Chu, J. W. K. (1996) · Biochemical Journal · doi:10.1042/bj3200421 · Cited by 108
Chronic measurement of cardiac output in conscious mice
Janssen, B. J., Debets, J., Leenders, P. J. A., & Smits, J. F. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00406.2001 · Cited by 101
Kuszyk, B. S., Corl, F. M., Franano, F. N., Bluemke, D. A., Hofmann, L. V., Fortman, B. J., & Fishman, E. K. (2001) · American Journal of Roentgenology · doi:10.2214/ajr.177.4.1770747 · Cited by 88
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex
Kato, M., Hattori, Y., Kubo, M., & Maitani, Y. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.015 · Cited by 86
Yu, M., & Tannock, I. F. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.002 · Cited by 84
The mechanism of 67Ga localization in malignant disease
Weiner, R. E. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00119-9 · Cited by 83
A model for temporal heterogeneities of tumor blood flow
Mollica, F. (2003) · Microvascular Research · doi:10.1016/s0026-2862(02)00012-2 · Cited by 62
Alderden, R. A., Mellor, H. R., Modok, S., Hall, M. D., Sutton, S. R., Newville, M. G., Callaghan, R., & Hambley, T. W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja076281t · Cited by 60
Mayer, L. D., Dougherty, G. J., Harasym, T. O., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36522-x · Cited by 59
Nuclear envelope barrier leak induced by dexamethasone
Kastrup, L., Oberleithner, H., Ludwig, Y., Schafer, C., & Shahin, V. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20479 · Cited by 58
Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis
Symens, N., Soenen, S. J., Rejman, J., Braeckmans, K., Smedt, S. C. D., & Remaut, K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.012 · Cited by 57
Tall, A. R. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39815-1 · Cited by 54
Induction of multiple‐drug resistance during anti‐neoplastic chemotherapy in vitro
Licht, T., Fiebig, H., Bross, K., Herrmann, F., Berger, D. P., Shoemaker, R. H., & Mertelsmann, R. H. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490427 · Cited by 51
Graff, B. A., Benjaminsen, I. C., Brurberg, K. G., Ruud, E. M., & Rofstad, E. K. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20265 · Cited by 45
Zheng, X., Goins, B., Cameron, I. L., Santoyo, C., Bao, A., Frohlich, V. C., & Fullerton, G. D. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1305-1 · Cited by 43
Pilloni, M., Nicolas, J., Marsaud, V., Bouchemal, K., Frongia, F., Scano, A., Ennas, G., & Dubernet, C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.09.010 · Cited by 39
Eckes, J., Schmah, O., Siebers, J. W., Groh, U., Zschiedrich, S., Rautenberg, B., Hasenburg, A., Jansen, M., Hug, M. J., Winkler, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-337 · Cited by 35
Targeting Tumors Using Estrogen Receptor Ligand Conjugates
Keely, N. O., & Meegan, M. J. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166628 · Cited by 17
Cited by
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Naksuriya, O., Okonogi, S., Schiffelers, R. M., & Hennink, W. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.090 · Cited by 841
Metadata
- Authors
- Nichols, J. W., & Bae, Y. H.
- Venue
- Nano Today
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 7
- Issue
- 6
- Pages
- 606-618
- ISSN
- 1748-0132 (ISSN-L)
- OpenAlex
- W2062357348
- Cited by
- 364
- References
- 104
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.